Efficacy of Hedgehog Pathway Inhibitors as Adjuvant in Treating Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease.

Andres Mendez-Hernandez Ridhi Gupta Sally Arai Robert Lowsky Bernice Kwong Wen-Kai Weng

J Am Acad Dermatol

Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, CA; Department of Dermatology, Stanford University, Stanford, CA. Electronic address:

Published: January 2025

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jaad.2025.01.024	DOI Listing

Publication Analysis

Top Keywords

efficacy hedgehog

hedgehog pathway

pathway inhibitors

inhibitors adjuvant

adjuvant treating

treating steroid-refractory

steroid-refractory sclerodermatous

sclerodermatous chronic

chronic graft-versus-host

graft-versus-host disease

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!